Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

Inclusion Criteria: * Female or male patients at least 18 years of age * Patients who are at serious risk of hypertrophic scarring (due to family history, race, recent surgery, etc) * Able and willing to provide informed consent and likely to complete all study visits * All Fitzpatrick skin types will be evaluated Exclusion Criteria: * Known contraindications to Dermatix or any of its components * Age of scar is \> 4 months * Keloid scars (scars with increased fibroblastic activity that has exceeded the boundaries of the original scar)